Extended and stable gene expression via nucleofection of MIDGE construct into adult human marrow mesenchymal stromal cells

Cytotechnology

Volumn 64, Issue 2, 2012, Pages 203-216

  Mok, P L ^a,c   Cheong, S K ^a,b   Leong, C F ^c   Chua, K H ^c   Ainoon, O ^c,d  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

^c DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^d UNIVERSITI SAINS ISLAM MALAYSIA   (Malaysia)

Author keywords

Bone marrow mesenchymal stromal cells; Cationic lipofection; Erythropoietin; MIDGE; Nucleofection

Indexed keywords

ERYTHROPOIETIN; LIPOFECTAMINE; LUCIFERASE; PLASMID DNA;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONSTRUCT; GENE EXPRESSION; GENE TECHNOLOGY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTERMETHOD COMPARISON; MESENCHYMAL STROMA CELL; NONVIRAL GENE DELIVERY SYSTEM; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM;

CHIRONOMIDAE; EUKARYOTA; PROKARYOTA;

EID: 84859157173     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-011-9413-2     Document Type: Article

References (52)

1. Aluigi M, Fogli M, Curti A, Isidori A, Gruppioni E, Chiodoni C, Colombo MP, Versura P, D'Errico-Grigioni A, Ferri E, Baccarani M, Lemoli RM (2006) Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells. Stem Cells 24:454-461 (Pubitemid 44464815)
2. Baskin S, Lasker N (1990) Erythropoietin-associated hypertension. New Engl J Med 323:999
3. Bennett CL, Luminari S, Nissenson AR, Tallman MS, Klinge SA, Mc Williams N, McKoy JM, Kim B, Lyons EA, Tri- filio SM, Rasich DW, Evens AM, Kuzel TM, Schumock GT, Belknap SM, Locatelli F, Rossert J, Casadevall N (2004) Pure red-cell aplasia and epoetin therapy. New Engl J Med 351:1403-1408
4. Bonetta L (2005) The inside scoop-evaluating gene delivery methods. Nat Methods 2:875-883
5. Brines M, Cerami A (2008) Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J Intern Med 264:405-432
6. Bruenker HG (2006) Efficiency transfection of primary cells for basic research and gene therapy. Mol Ther 13:215
7. Chan J, O'Donoghue K, Fuente JDL, Roberts IA, Kumar S, Morgan JE, Fisk NM (2006) Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 23:93-102
8. Chen HH, Cawood R, Seymour LW (2008) Toward more effective gene delivery. Genome Biol 9:301
9. Choong PF, Mok PL, Cheong SK, Leong CF, Then KY (2007) Generating neuron-like cells from BM-derived mesenchymal stromal cells in vitro. Cytother 9:170-183
10. Copland IB, Jolicoeur EM, Gilis M, Cuerquis J, Eliopoulos N, Annabi B, Calderone A, Tanguay J, Ducharme A, Galipeau J (2008) Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties. Cardiovasc Res 79:405-415
11. Deng Y, Guo X, Yuan Q, Li S (2003) Efficiency of adenoviral vector mediated CTLA4Ig gene delivery into mesenchymal stem cells. Chin Med J 116:1649-1654 (Pubitemid 38008231)
12. Doering CB (2008) Retroviral modification of mesenchymal stem cells for gene therapy of hemophilia A. Methods Mol Biol 433:203-212
13. Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S, Agricola B, Byrne E, Raffeld M, Moen R, Bacher J, Zsebo KM, Nienhuis AW (1992) Helper virus induced T-cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 176:1125-1135
14. Esneault E, Pacary E, Eddi D, Freret T, Tixier E, Toutain J, Touzani O, Schumann-Bard P, Petit E, Roussel S, Bernaudin M (2008) Combined therapeutic strategy using erythropoietin and mesenchymal stem cells potentiates neurogenesis after transient focal cerebral ischemia in rats. J Cerebr Blood Flow Metab 28:1552-1563
15. Gao X, Kim KS, Liu D (2007) Nonviral gene delivery: what we know and what is next. AAPS J 9:E92-E104
16. Gheisari Y, Soleimani M, Azadmanesh K, Zeinali S (2008) Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods. Cytother 10:815-823
17. Ghezzi P, Brines M (2004) Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 11:S37-S44 (Pubitemid 39136797)
18. Helledie T, Nurcombe V, Cool SM (2008) A simple and reliable electroporation method for human bone marrow mesenchymal stem cells. Stem Cells Dev 17:837-848
19. Heller L, Jaroszeski MJ, Coppola D, Pottinger C, Gilbert R, Heller R (2000) Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo. Gene Ther 7:826-829 (Pubitemid 30303578)
20. Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, Nguyen AT, Malide D, Combs CA, Hall G, Zhang J, Raffeld M, Rogers TB, Stetler-Stevenson W, Frank JA, Reitz M, Finkel T (2006) Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 203:1235-1247 (Pubitemid 43736593)
21. Kidd S, Caldwell L, Dietrich M, Samudio I, Spaeth EL, Watson K, Shi Y, Abbruzzese J, Konopleva M, Andreeff M, Marini FC (2010) Mesenchymal stromal cells alone or expessing interferon-β suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment. Cytother 12:615-625
22. Lenz P, Bacot SM, Frazier-Jessen MR, Feldman GM (2003) Nucleofection of dendritic cells: efficient gene transfer by electroporation into human monocyte-derived dendritic cells. FEBS Lett 538:149-154 (Pubitemid 36287441)
23. Leutenegger CM, Boretti FS, Mislin CN, Flynn JN, Schroff M, Habel A, Junghans C, Koenig-Merediz SA, Sigrist B, Aubert A, Pedersen NC, Wittig B, Lutz H (2000) Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline Interleukin-12 (IL-12), IL-16, or a CpG motif. J Virol 74:10447-10457
24. Lieutaud T, Andrews PJ, Rhodes JK, Williamson R (2008) Characterization of the pharmacokinetics of human recombinant erythropoietin in blood and brain when administered immediately after lateral fluid percussion brain injury and its pharmacodynamic effects on IL-1 beta and MIP-2 in rats. J Neurotrauma 25:1179-1185
25. Lim JY, Park SH, Jeong CH, Oh JH, Kim SM, Ryu CH, Park SA, Ahn JG, Oh W, Jeun SS, Chang JW (2010) Microporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cells. BMC Biotechnol 10:38
26. Loo M, Beguin Y (1999) The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. Blood 93:3286-3293 (Pubitemid 29220895)
27. López-Fuertes L, Pérez-Jiménez E, Vila-Coro AJ, Sack F, Moreno S, Konig SA, Junghans C, Wittig B, Timón M, Esteban M (2002) DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice. Vaccine 21:247-257 (Pubitemid 35346820)
28. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infracted hearts. Nature 9:1195-1201 (Pubitemid 37173705)
29. Maruyama K (2005) Liposomes. Taira K, Kataoka K, Niidome T (eds) Non-viral gene therapy, Springer-Verlag, Tokyo, pp:19-34, In
30. Mok PL, Leong CF, Cheong SK (2003) Isolation and identifi- cation of mesenchymal stem cells from human bone marrow. Malays J Pathol 25:121-127
31. Mok PL, Cheong SK, Leong CF (2008a) In vitro differentiation study on isolated human mesenchymal stem cells. Malays J Pathol 30:11-19
32. Mok PL, Cheong SK, Leong CF, Othman A (2008b) In vitro expression of erythropoietin by transfected human mesenchymal stromal cells. Cytother 10:116-124
33. Moreno S, López-Fuertes L, Vila-Coro AJ, Sack F, Smith CA, Konig SA, Wittig B, Schroff M, Juhls C, Junghans C, Timón M (2004) DNA immunization with minimalistic expression constructs. Vaccine 22:1709-1716 (Pubitemid 38447219)
34. Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, Bizen A, Honmou O, Niitsu Y, Hamada H (2004) Antitumour effect of genetically engineered mesenchymal stromal cells in a rat glioma model. Gene Ther 11:1155-1164 (Pubitemid 39117311)
35. Nakashima S, Matsuyama Y, Nitta A, Sakai Y, Ishiguro N (2005) Highly efficient transfection of human marrow stromal cells by nucleofection. Transplant Proc 37:2290-2292 (Pubitemid 40956434)
36. Parekkadan B, Milwid JM (2010) Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12:87-117
37. Patil SD, Rhodes DG, Burgess DJ (2005) DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J 7:E61-E77 (Pubitemid 41554297)
38. Pittenger MF, Martin BJ (2004) Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95: 9-20 (Pubitemid 38931831)
39. Reiser J, Zhang XY, Hemenway CS, Mondal D, Pradhan L, Russa VFL (2005) Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin Biol Ther 5:1571-1584 (Pubitemid 41771848)
40. Ross PC, Hui SW (1999) Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther 6:651-659 (Pubitemid 29192674)
41. Rossert J, Eckardt KU (2005) Erythropoietin receptors: their role beyond erythropoiesis. Nephrol Dial Transplant 20:1025-1028 (Pubitemid 40862086)
42. Sasportas LS, Kasmieh R, Wakimoto H, Hingtgen S, van de Water JAJM, Mohapatra G, Figueiredo JL, Martuza RL, Weissleder R, Shah K (2009) Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci USA 106: 4822-4827
43. Schakowski F, Gorschlüter M, Junghans C, Schroff M, Buttgereit P, Ziske C, Schöttker B, König-Merediz SA, Sauerbruch T, Wittig B, Schmidt-Wolf IGH (2001) A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfections of undesired DNA. Mol Ther 3:793-800 (Pubitemid 32509876)
44. Thomas CE, Ehrhardt A, KayMA(2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4:346-358 (Pubitemid 36538359)
45. Tomita M, Adachi Y, Yamada H, Takahashi K, Kiuchi K, Oyaizu H, Ikebukuro K, Kaneda H, Matsumura M, Ikehara S (2002) Bone marrow-derived stem cells can differentiate into retinal cells in injured rat retina. Stem Cells 20:279-283 (Pubitemid 34765086)
46. Van Damme A, Chuah KL, Dell'accio F, De Bari D, Luyten F, Collen D, VandenDriessche T (2003) Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats. Haemophilia 9:94-103 (Pubitemid 36511640)
47. Vorburger SA, Hunt KK (2002) Adenoviral gene therapy. Oncologist 7:46-59 (Pubitemid 34151107)
48. Wang Z, Troilo PJ, Wang X, Griffiths II TG, Pacchione SJ, Barnum AB, Harper LB, Pauley CJ, Niu Z, Denisova L, Follmer TT, Rizzuto G, Ciliberto G, Fattori E, Monica NL, Manam S, Ledwith BJ (2004) Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation. Gene Ther 11: 711-721 (Pubitemid 38519279)
49. Wong CY, Cheong SK, Mok PL, Leong CF (2008) Differentiation of human mesenchymal stem cells into mesangial cells in post-glomerular injury murine model. Pathology 40:52-57
50. Yen BL, Yen ML (2008) Mesenchymal stem cells and cancer - for better or for worse? J Cancer Mol 4:5-9
51. Zarogasi LE, Billon N, Ailhaud G, Dani C (2007) Nucleofection is a valuable transfection method for transient and stable transgene expression in adipose tissue-derived stem cells. Stem Cells 25:790-797 (Pubitemid 46354239)
52. Zhang Y (2007) Microinjection technique and protocol to single cells. http://www.nature.com/protocolexchange/protocols/376. Accessed 27 May 2011